Tenascin C levels in patients with mild and severe preeclampsia
| dc.contributor.author | Orak, Ugur | |
| dc.contributor.author | Celik, Ebru | |
| dc.contributor.author | Kavak, Salih Burcin | |
| dc.contributor.author | Demirel, Ismail | |
| dc.contributor.author | Atilgan, Remzi | |
| dc.contributor.author | Aydin, Suleyman | |
| dc.contributor.author | Sapmaz, Ekrem | |
| dc.date.accessioned | 2026-08-12T17:16:59Z | |
| dc.date.issued | 2016 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | Objective: To determine the serum tenascin-C (TN-C) levels in cases with mild and severe preeclampsia.Methods: Pregnant women were divided into three groups, namely healthy pregnants (Group 1, n=20), pregnants with mild preeclampsia (Group 2, n=20) and pregnants with severe preeclampsia (Group 3, n=20). The groups were formed so as to match each other in terms of gestational week. From each pregnant woman, pre- and post-delivery blood samples were obtained to measure serum TN-C levels. The data were evaluated using the Kruskall-Wallis variance analysis. For the obtained values of p<0.05, the groups were compared in pairs. A p value of <0.017 was accepted as significant.Results: In Groups 1, 2 and 3, the prepartum TN-C levels were 5.020.4 mu g/ml, 12.8 +/- 2.9 mu g/ml and 33.8 +/- 11.7 mu g/ml, and in the postpartum TN-C levels were 4.7 +/- 0.1 mu g/ml, 11.7 +/- 1.8 mu g/ml and 50.6 +/- 33.8 mu g/ml, respectively. There was a significant difference between the groups in terms of the prepartum and postpartum TN-C levels (p<0.017, Mann-Whitney U [MWU] test). There was also a significant difference in the prepartum TN-C levels between Groups 2 and 3 (p<0.017, MWU test).Conclusions: The prepartum and postpartum TN-C levels were significantly higher in mild and severe preeclampsia than those in healthy pregnants. | |
| dc.identifier.doi | 10.3109/14767058.2014.998191 | |
| dc.identifier.endpage | 273 | |
| dc.identifier.issn | 1476-7058 | |
| dc.identifier.issn | 1476-4954 | |
| dc.identifier.issue | 2 | |
| dc.identifier.orcid | 0000-0002-0774-4294 | |
| dc.identifier.pmid | 25567561 | |
| dc.identifier.scopus | 2-s2.0-84983189792 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 270 | |
| dc.identifier.uri | https://doi.org/10.3109/14767058.2014.998191 | |
| dc.identifier.uri | https://hdl.handle.net/11508/52499 | |
| dc.identifier.volume | 29 | |
| dc.identifier.wos | WOS:000365628300019 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Taylor & Francis Ltd | |
| dc.relation.ispartof | Journal of Maternal-Fetal & Neonatal Medicine | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.subject | Cytokine | |
| dc.subject | preeclampsia | |
| dc.subject | tenascin-C | |
| dc.title | Tenascin C levels in patients with mild and severe preeclampsia | |
| dc.type | Article |







